4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-001671
Chief Operating Officer sold 3,490 shares at $4.06 ($14,184)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bertrand William C JR Chief Operating Officer | 2022-01-04 | Sale | −3,490 | $4.06 | $14,184 | 5,873 | D |
| Open-market sales · 3,490 sh · avg $4.06 · $14,184 | |||||||
Loading xslF345X03/tm221700-4_4seq1.xml…